BRPI0410926A - análogos de 3-oxa-8-azaprostaglandinas como agentes para reduzir a pressão intraocular - Google Patents
análogos de 3-oxa-8-azaprostaglandinas como agentes para reduzir a pressão intraocularInfo
- Publication number
- BRPI0410926A BRPI0410926A BRPI0410926-0A BRPI0410926A BRPI0410926A BR PI0410926 A BRPI0410926 A BR PI0410926A BR PI0410926 A BRPI0410926 A BR PI0410926A BR PI0410926 A BRPI0410926 A BR PI0410926A
- Authority
- BR
- Brazil
- Prior art keywords
- oxa
- agents
- intraocular pressure
- azaprostaglandins
- analogues
- Prior art date
Links
- 230000004410 intraocular pressure Effects 0.000 title abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 2
- 206010030043 Ocular hypertension Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/453,207 US6734206B1 (en) | 2003-06-02 | 2003-06-02 | 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| PCT/US2004/016516 WO2004108670A1 (en) | 2003-06-02 | 2004-05-25 | 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410926A true BRPI0410926A (pt) | 2006-06-27 |
Family
ID=32230466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410926-0A BRPI0410926A (pt) | 2003-06-02 | 2004-05-25 | análogos de 3-oxa-8-azaprostaglandinas como agentes para reduzir a pressão intraocular |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6734206B1 (enExample) |
| EP (1) | EP1638936B1 (enExample) |
| JP (1) | JP2006526638A (enExample) |
| AT (1) | ATE496886T1 (enExample) |
| AU (1) | AU2004245492B2 (enExample) |
| BR (1) | BRPI0410926A (enExample) |
| CA (1) | CA2528010C (enExample) |
| DE (1) | DE602004031225D1 (enExample) |
| ES (1) | ES2358513T3 (enExample) |
| WO (1) | WO2004108670A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6734201B1 (en) * | 2003-06-02 | 2004-05-11 | Allergan, Inc. | 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| EP1960353B1 (en) | 2005-11-03 | 2014-03-12 | Allergan, Inc. | Prostaglandins and analogues as agents for lowering intraocular pressure |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| US8783923B2 (en) * | 2010-03-18 | 2014-07-22 | Chung Yuan Christian University | Auto lamp structure |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028624A (en) | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
| US5034413A (en) | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
| CA2021316C (en) | 1989-07-27 | 2000-10-24 | Ming Fai Chan | Intraocular pressure reducing 11-acyl prostaglandins |
| US4994274A (en) | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
| AU2211700A (en) * | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Prostaglandin e agonists for treatment of glaucoma |
| OA12117A (en) * | 1999-12-22 | 2006-05-04 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
| DK1132086T3 (da) | 2000-01-31 | 2006-08-28 | Pfizer Prod Inc | Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt |
| US20010056060A1 (en) | 2000-02-07 | 2001-12-27 | Cameron Kimberly O. | Treatment of osteoporsis with EP2/EP4 receptor selective agonists |
| JP4063468B2 (ja) | 2000-02-22 | 2008-03-19 | 株式会社カネボウ化粧品 | 寒天被覆処理顔料およびメイクアップ化粧料 |
| WO2002024647A1 (en) | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| NZ525164A (en) * | 2000-11-27 | 2005-04-29 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
| JP4520738B2 (ja) * | 2001-06-14 | 2010-08-11 | アラーガン インコーポレイテッド | 眼圧降下剤としての３、７、または３および７チアまたはオキサプロスタン酸誘導体 |
| BR0211201A (pt) * | 2001-07-16 | 2004-07-13 | Hoffmann La Roche | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero |
| ES2289140T3 (es) * | 2001-07-16 | 2008-02-01 | F. Hoffmann-La Roche Ag | Derivados de 2-pirrolidona como agonistas de prostanoide. |
| TWI313608B (en) | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| BR0308738A (enExample) * | 2002-03-18 | 2005-01-11 | ||
| EP1490055A1 (en) * | 2002-03-18 | 2004-12-29 | Pfizer Products Inc. | Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension |
-
2003
- 2003-06-02 US US10/453,207 patent/US6734206B1/en not_active Expired - Fee Related
-
2004
- 2004-05-25 BR BRPI0410926-0A patent/BRPI0410926A/pt not_active IP Right Cessation
- 2004-05-25 AU AU2004245492A patent/AU2004245492B2/en not_active Ceased
- 2004-05-25 AT AT04753359T patent/ATE496886T1/de not_active IP Right Cessation
- 2004-05-25 ES ES04753359T patent/ES2358513T3/es not_active Expired - Lifetime
- 2004-05-25 WO PCT/US2004/016516 patent/WO2004108670A1/en not_active Ceased
- 2004-05-25 JP JP2006514964A patent/JP2006526638A/ja active Pending
- 2004-05-25 DE DE602004031225T patent/DE602004031225D1/de not_active Expired - Lifetime
- 2004-05-25 CA CA2528010A patent/CA2528010C/en not_active Expired - Fee Related
- 2004-05-25 EP EP04753359A patent/EP1638936B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE496886T1 (de) | 2011-02-15 |
| WO2004108670A1 (en) | 2004-12-16 |
| JP2006526638A (ja) | 2006-11-24 |
| US6734206B1 (en) | 2004-05-11 |
| DE602004031225D1 (de) | 2011-03-10 |
| CA2528010C (en) | 2012-01-24 |
| AU2004245492A1 (en) | 2004-12-16 |
| EP1638936B1 (en) | 2011-01-26 |
| CA2528010A1 (en) | 2004-12-16 |
| EP1638936A1 (en) | 2006-03-29 |
| ES2358513T3 (es) | 2011-05-11 |
| AU2004245492B2 (en) | 2010-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0310047A (pt) | Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular | |
| BRPI0412347A (pt) | 2-aminofenil-4-fenilpiridinas como inibidores de quinase | |
| ATE359794T1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
| BRPI0517423A (pt) | composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto | |
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| BR0010555A (pt) | Inibidores de neuraminidases | |
| BRPI0518222A (pt) | composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos | |
| BR0316753A (pt) | Método de tratamento para disfunção sexual | |
| MX9600484A (es) | Anhidrato de clorhidrato de paroxetina y procedimiento para su preparacion. | |
| DE69924254D1 (de) | Verwendung von a3-adenosine antagonisten zur herstellung eines arzneimittels zur senkung des augeninnendrucks | |
| WO2003072066A3 (en) | Compositions and methods for the treatment of glaucoma and ocular hypertension | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| EA200800303A1 (ru) | Применение производных и аналогов тиазола при нарушениях, вызванных свободными жирными кислотами | |
| DK1395263T3 (da) | 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk | |
| EA200970436A1 (ru) | Соединения карбамата для лечения депрессии | |
| BR9907715A (pt) | Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose | |
| BRPI0410926A (pt) | análogos de 3-oxa-8-azaprostaglandinas como agentes para reduzir a pressão intraocular | |
| BRPI0407400A (pt) | derivados do ácido 10,10-dialquil prostanóico como agentes para o abaixamento de pressão intra-ocular | |
| DE60130030D1 (de) | Verfahren zur behandlung von glaukom | |
| BR9909870A (pt) | Pirrolidinas como inibidores de neuraminidases | |
| BR0316775A (pt) | Novos análogos de benzopirano e seu uso para o tratamento de glaucoma | |
| CY1112146T1 (el) | Βακτηριοκτονος συνθεση για αγροτικη ή κηπουρικη χρηση και μεθοδος ελεγχου ασθενειας φυτου | |
| MX2007011814A (es) | Compuestos citoesqueleticos activos, composiciones y usos. | |
| BRPI0411057A (pt) | análogos de prostaglandina e de piperidinila |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |